BlackRock's long position in CSPC Pharmaceutical Group increased to 5.16%.

According to disclosures from the Hong Kong Stock Exchange, BlackRock's long position in CSPC Pharmaceutical Group Limited increased from 4.55% to 5.16% on October 8, 2026.